Alpha Crest Capital Management LLC Dynavax Technologies Corp Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$7.45 - $12.83 $1.03 Million - $1.77 Million
-138,081 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$9.75 - $14.44 $448,363 - $664,037
45,986 Added 49.93%
138,081 $1.5 Million
Q4 2021

Feb 09, 2022
BUY
$13.17 - $20.94 $1.21 Million - $1.93 Million
92,095 New
92,095 $1.3 Million
Q3 2019

Nov 12, 2019
SELL
$2.69 - $4.85 $47,882 - $86,330
-17,800 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$7.08 - $12.09 $126,024 - $215,202
17,800 New
17,800 $130,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email